Annual CFF
$118.70 M
-$106.27 M-47.24%
31 December 2023
Summary:
HilleVax annual cash flow from financing activities is currently $118.70 million, with the most recent change of -$106.27 million (-47.24%) on 31 December 2023. During the last 3 years, it has risen by +$117.37 million (+8851.58%). HLVX annual CFF is now -47.24% below its all-time high of $224.97 million, reached on 31 December 2022.HLVX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$27.50 M
-$28.11 M-4571.06%
30 September 2024
Summary:
HilleVax quarterly cash flow from financing activities is currently -$27.50 million, with the most recent change of -$28.11 million (-4571.06%) on 30 September 2024. Over the past year, it has dropped by -$135.60 million (-125.43%). HLVX quarterly CFF is now -112.60% below its all-time high of $218.20 million, reached on 30 June 2022.HLVX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$11.51 M
-$135.60 M-109.27%
30 September 2024
Summary:
HilleVax TTM cash flow from financing activities is currently -$11.51 million, with the most recent change of -$135.60 million (-109.27%) on 30 September 2024. Over the past year, it has dropped by -$139.58 million (-108.98%). HLVX TTM CFF is now -103.28% below its all-time high of $350.56 million, reached on 30 June 2022.HLVX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HLVX Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -47.2% | -125.4% | -109.0% |
3 y3 years | +8851.6% | -3385.0% | -108.6% |
5 y5 years | - | - | - |
HLVX Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -47.2% | +8851.6% | -112.6% | at low | -103.3% | at low |
5 y | 5 years | -47.2% | +8851.6% | -112.6% | at low | -103.3% | at low |
alltime | all time | -47.2% | +8851.6% | -112.6% | at low | -103.3% | at low |
HilleVax Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$27.50 M(-4571.1%) | -$11.51 M(-109.3%) |
June 2024 | - | $615.00 K(-95.9%) | $124.10 M(-7.2%) |
Mar 2024 | - | $15.06 M(+4712.1%) | $133.68 M(+12.6%) |
Dec 2023 | $118.70 M(-47.2%) | $313.00 K(-99.7%) | $118.70 M(-7.3%) |
Sept 2023 | - | $108.11 M(+960.1%) | $128.07 M(+647.0%) |
June 2023 | - | $10.20 M(>+9900.0%) | $17.14 M(-92.4%) |
Mar 2023 | - | $80.00 K(-99.2%) | $225.15 M(+0.1%) |
Dec 2022 | $224.97 M | $9.69 M(-443.5%) | $224.97 M(+4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2022 | - | -$2.82 M(-101.3%) | $214.49 M(-38.8%) |
June 2022 | - | $218.20 M(<-9900.0%) | $350.56 M(+161.4%) |
Mar 2022 | - | -$99.00 K(-87.5%) | $134.11 M(-0.1%) |
Dec 2021 | $134.21 M(>+9900.0%) | - | - |
Dec 2021 | - | -$789.00 K(-100.6%) | $134.21 M(-0.6%) |
Sept 2021 | - | $133.25 M(+7509.9%) | $135.00 M(+7609.9%) |
June 2021 | - | $1.75 M(>+9900.0%) | $1.75 M(>+9900.0%) |
Mar 2021 | - | $0.00 | $0.00 |
Dec 2020 | $1.33 M | - | - |
FAQ
- What is HilleVax annual cash flow from financing activities?
- What is the all time high annual CFF for HilleVax?
- What is HilleVax annual CFF year-on-year change?
- What is HilleVax quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for HilleVax?
- What is HilleVax quarterly CFF year-on-year change?
- What is HilleVax TTM cash flow from financing activities?
- What is the all time high TTM CFF for HilleVax?
- What is HilleVax TTM CFF year-on-year change?
What is HilleVax annual cash flow from financing activities?
The current annual CFF of HLVX is $118.70 M
What is the all time high annual CFF for HilleVax?
HilleVax all-time high annual cash flow from financing activities is $224.97 M
What is HilleVax annual CFF year-on-year change?
Over the past year, HLVX annual cash flow from financing activities has changed by -$106.27 M (-47.24%)
What is HilleVax quarterly cash flow from financing activities?
The current quarterly CFF of HLVX is -$27.50 M
What is the all time high quarterly CFF for HilleVax?
HilleVax all-time high quarterly cash flow from financing activities is $218.20 M
What is HilleVax quarterly CFF year-on-year change?
Over the past year, HLVX quarterly cash flow from financing activities has changed by -$135.60 M (-125.43%)
What is HilleVax TTM cash flow from financing activities?
The current TTM CFF of HLVX is -$11.51 M
What is the all time high TTM CFF for HilleVax?
HilleVax all-time high TTM cash flow from financing activities is $350.56 M
What is HilleVax TTM CFF year-on-year change?
Over the past year, HLVX TTM cash flow from financing activities has changed by -$139.58 M (-108.98%)